Data firm: Global spending on drugs slows to 2016

Published



TRENTON, N.J. (AP) — Growth in global spending on medications will slow markedly over the next four years due to a slew of new low-cost generic drugs coming to pharmacies in the U.S. and other developed countries, along with slower increases in what those countries spend on brand-name drugs, according to a new forecast.

That’s good news for patients and the employers, labor unions and taxpayer-funded government health programs that help pay for drugs.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.